Information
Arsell Recalls Benadryl Liquid Elixir 100 mL Bottle Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging; Sold on Amazon.com
The CPSC record for this recall reports no injuries. Consumers should stop using the product and follow the recall remedy.
Source: CPSC
InfoRecall #25194
Arsell Recalls Benadryl Liquid Elixir 100 mL Bottle Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging; Sold on Amazon.com
Arsell Inc., of Brooklyn, New York · Benadryl Liquid Elixir, 100 mL bottles
Product Description
This recall involves Benadryl Liquid Elixir sold in a round dark plastic bottle with a pink and white label on the front with the word "Benadryl" in blue text. The product contains 100 mL of Benadryl. The back label contains safety disclosures, storage instructions and manufacturer information. The product was packaged in a paper box decorated with pink and white with the word "Benadryl" written in blue text. The package has a white label on the bottom with the following code written in black text: "X003VRIGUL."
Hazard
The Benadryl contains diphenhydramine, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the Benadryl out of the sight and reach of children and contact Arsell for a full refund. Consumers will be asked to submit their Amazon order number and a photo demonstrating disposal of the recalled Benadryl to recall@arsellsupport.com. Only the bottle is being recalled, not the medicine itself, but both should be disposed of. All known purchasers are being contacted directly.
Refund
411 Press Analysis
The CPSC announced a voluntary recall of Benadryl Liquid Elixir, 100 mL bottles on March 20, 2025. The Benadryl contains diphenhydramine, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. This recall covers about 2,300 units and was initiated by Arsell Inc., of Brooklyn, New York. The CPSC’s incident record for this recall states that no injuries have been reported. Consumers should stop using the product and obtain a full refund. Consumers can verify whether their product is affected by checking model numbers against the CPSC listing.
This recall appears in: Drug & Medication Defects.
More CPSC recalls